Stay updated on AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Sign up to get notified when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.

Latest updates to the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded note that publications are automatically filled in from PubMed. Revision updated to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedDeleted the government funding/operating status notice from the page. The AREDS2 study details, eligibility, and related links remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedNo significant changes to the study record content; the two screenshots show the same sections with only minor layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check69 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedUpdated page revision to v3.0.2; removed v3.0.1 and the 'Back to Top' link.SummaryDifference0.1%

Stay in the know with updates to AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Enter your email address, and we'll notify you when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.